WASHINGTON—Maxine Frank Singer, chief of the biochemistry laboratory at NIH's National Cancer Institute, has been named the next president of the Carnegie Institution of Washington. Singer, a molecular biologist, will succeed James Ebert, who has been president since 1978.

Founded by Andrew Carnegie in 1902, the private, nonprofit Institution has an annual budget of $16 million. It supports research in biology, astronomy and the earth sciences by 60 scientists and 120 fellows at five centers in the United States and Chile.

"Carnegie stands for tremendous excellence in science," said Singer. "It has a reputation for breaking new ground in important areas of research, for being adventurous in what it is willing to support, and for being small enough to be flexible."

Singer, 56, will become the first woman to lead the institution when she assumes her position March 1, 1988. She said she hopes to continue her research at NIH...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?